`Patent No. 10,407,458
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Filed: March 30, 2021
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________
`
` ILLUMINA, INC.,
`Petitioner,
`
`v.
`
` THE TRUSTEES OF COLUMBIA UNIVERSITY
`IN THE CITY OF NEW YORK
`Patent Owner.
`_______________
`
`IPR2020-00988 (Patent 10,407,458)
`
`
`
`PATENT OWNER’S UPDATED EXHIBIT LIST
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2020-00988
`Patent No. 10,407,458
`
`
`Pursuant to 37 C.F.R. § 42.63(e), Patent Owner The Trustees of Columbia
`
`University in the City of New York hereby provides an updated list of its exhibits
`
`in this proceeding.
`
`Exhibit No. Description
`
`EXHIBIT LIST
`
`2001
`
`2002
`
`2003
`
`2004
`
`2005
`
`2006
`
`2007
`
`2008
`
`2009
`
`2010
`
`Defendant Illumina, Inc.’s Response to Plaintiffs’ Opening Claim
`Construction Brief
`
`Metzker, et al., “Elimination of residual natural nucleotides from
`3’-O-modified-dNTP syntheses by enzymatic mop-up,”
`BioTechniques, 25:814-817 (1998)
`PCT Publication WO 00/53805 (“Stemple”)
`
`Defendant Illumina, Inc.’s Initial Invalidity Contentions, The
`Trustees of Columbia University in the City of New York and
`Qiagen Sciences, LLC v. Illumina, Inc., 19-cv-01681 (D. Del.)
`U.S. Patent No. 6,087,095 (“Rosenthal”)
`
`Welch & Burgess, “Synthesis of fluorescent, photolabile 3’-O-
`protected nucleoside triphosphates for the base addition
`sequencing scheme,” Nucleosides & Nucleotides, 18:197-201
`(1999)
`Canard & Sarfati, “DNA polymerase fluorescent substrates with
`reversible 3’-tags,” Gene, 148:1-6 (1994)
`
`IPR2017-02172 Petition for Inter Partes Review of U.S. Patent
`No. 7,566,537
`
`IPR2017-02172 Preliminary Response of Patent Owner Illumina
`Cambridge Ltd.
`
`IPR2017-02174 Preliminary Response of Patent Owner Illumina
`Cambridge Ltd.
`
`2011
`
`IPR2013-00517 Illumina’s Patent Owner Response
`
`
`
`1
`
`
`
`Case IPR2020-00988
`Patent No. 10,407,458
`
`
`2012
`
`IPR2013-00517 Final Written Decision
`
`2013
`
`IPR2013-00517 Deposition of Floyd Romesberg, Ph.D., July 8,
`2014
`
`2014
`
`IPR2018-00291 Petitioner’s Reply
`
`2015
`
`U.S. Patent No. 5,808,045
`
`2016
`
`Curriculum Vitae of Kenneth A. Johnson, Ph.D.
`
`2017
`
`2018
`
`2019
`
`IPR2018-00291, IPR2018-00318, IPR2018-00322, IPR2018-
`00385, IPR2018-00797 Illumina’s Demonstratives for Oral
`Hearing
`IPR2018-00291, IPR2018-00318, IPR2018-00322, IPR2018-
`00385, IPR2018-00797 Illumina’s Reply to Patent Owner’s
`Opposition to Motion to Exclude
`IPR2018-00291 Institution Decision
`
`2020
`
`Declaration of Kenneth A. Johnson
`
`2021
`
`WO 96/23807 (“Kwiatkowski”)
`
`2022
`
`2023
`
`2024
`
`Ronaghi, et al. “A sequencing method based on real-time
`pyrophosphate,” Science, 281(5375):363-365 (1998)
`
`Brief of Patent Owner-Appellant Illumina Cambridge Ltd.,
`Illumina Cambridge Ltd. v. Intelligent Bio-Systems, Inc., D.I. 27,
`2015-1123 (Fed. Cir.)
`U.S. Patent No. 5,858,671 (“Jones”)
`
`2025
`
`U.S. Patent No. 6,013,445 (“Albrecht”)
`
`2026
`
`Excerpts from the Prosecution History of U.S. Patent No.
`9,718,852
`
`
`
`2
`
`
`
`Case IPR2020-00988
`Patent No. 10,407,458
`
`
`2027
`
`2028
`
`2029
`
`2030
`
`2031
`
`2032
`
`2033
`
`2034
`
`Complaint for Patent Infringement, The Trustees of Columbia
`University in the City of New York and Qiagen Sciences, LLC v.
`Illumina, Inc., D.I. 1, 19-cv-01681 (D. Del.)
`Docket, The Trustees of Columbia University in the City of New
`York and Qiagen Sciences, LLC v. Illumina, Inc., 19-cv-01681
`(D. Del.)
`Amended Complaint for Patent Infringement, The Trustees of
`Columbia University in the City of New York and Qiagen
`Sciences, LLC v. Illumina, Inc., D.I. 12, 19-cv-01681 (D. Del.)
`Exhibit 7 to Complaint for Patent Infringement, The Trustees of
`Columbia University in the City of New York and Qiagen
`Sciences, LLC v. Illumina, Inc., D.I. 1-7, 19-cv-01681 (D. Del.)
`Exhibit 8 to Complaint for Patent Infringement, The Trustees of
`Columbia University in the City of New York and Qiagen
`Sciences, LLC v. Illumina, Inc., D.I. 1-8, 19-cv-01681 (D. Del.)
`Docket, The Trustees of Columbia University in the City of New
`York and Qiagen Sciences, LLC v. Illumina, Inc., 19-2302 (Fed.
`Cir.)
`Zhu, Z., et al., “Directly labeled DNA probes using fluorescent
`nucleotides with different length linkers,” Nucleic Acids Res.,
`22:3418-3422 (1994)
`IPR2018-00291, Petition for Inter Partes Review of U.S. Patent
`No. 9,718,852
`
`2035
`
`U.S. Patent No. 7,566,537
`
`2036
`
`2037
`
`Joint Claim Construction Brief, The Trustees of Columbia
`University in the City of New York and Qiagen Sciences, LLC v.
`Illumina, Inc., D.I. 54, 19-cv-01681 (D. Del.)
`Excerpts of Joint Claim Construction Appendix (Declaration of
`John Kuriyan, Ph.D. in Support Of Plaintiffs’ Opening Claim
`Construction Brief; Expert Declaration of Dr. Floyd Romesberg in
`Support of Illumina’s Response to Plaintiffs’ Opening Claim
`Construction Brief), The Trustees of Columbia University in the
`City of New York and Qiagen Sciences, LLC v. Illumina, Inc., D.I.
`55, 19-cv-01681 (D. Del.)
`2038-2045 Reserved
`
`
`
`3
`
`
`
`Case IPR2020-00988
`Patent No. 10,407,458
`
`
`2046
`
`Protective Order, The Trustees of Columbia University in the City
`of New York and Qiagen Sciences, LLC v. Illumina, Inc., 19-cv-
`01681 (D. Del.)
`2047-2053 Reserved
`
`2054
`
`Excerpts from the Ex Parte Reexamination History of U.S. Patent
`No. 5,808,045
`
`2055-2058 Reserved
`
`2059
`
`Tabor, S. & C. C. Richardson, “A single residue in DNA
`polymerases of the Escherichia coli DNA polymerase I family is
`critical for distinguishing between deoxy- and
`dideoxyribonucleotides,” Proc. Natl. Acad. Sci. U.S.A.,
`92(14):6339-6343 (1995)
`2060-2070 Reserved
`
`2071
`
`2072
`
`2073
`
`Declaration of Kenneth A. Johnson, March 30, 2021, IPR2020-
`00988, -01065, -01125, -01177, -01323
`
`Deposition Transcript for Videotaped Deposition of Floyd
`Romesberg, Ph.D., March 15, 2021, IPR2020-00988, -01065, -
`01125, -01177, -01323
`Curriculum Vitae of Kenneth A. Johnson, Ph.D.
`
`2074
`
`EP 3 034 627 (“Columbia’s EP’627 patent”)
`
`2075
`
`2076
`
`Illumina’s October 29, 2019 Opposition against Columbia’s EP’627
`patent
`
`Illumina’s March 25, 2021 Response in support of its Opposition
`against Columbia’s EP’627 patent
`
`2077
`
`U.S. Patent No. 7,057,026 (“Barnes”)
`
`2078
`
`Johnson, K. A., “Conformational coupling in DNA polymerase
`fidelity,” Annu. Rev. Biochem., 62:685-713 (1993)
`
`
`
`4
`
`
`
`Case IPR2020-00988
`Patent No. 10,407,458
`
`
`2079
`
`2080
`
`2081
`
`2082
`
`2083
`
`2084
`
`2085
`
`2086
`
`2087
`
`2088
`
`2089
`
`Preliminary Opinion of Opposition Division re: Illumina’s
`Opposition against Columbia’s EP’627 patent
`
`Sluis-Cremer, N., D. Arion & M. A. Parniak, “Molecular
`mechanisms of HIV-1 resistance to nucleoside reverse transcriptase
`inhibitors (NRTIs),” Cell Mol Life Sci, 57(10):1408-1422 (2000)
`Koshland JR., D. E., “Enzyme flexibility and enzyme action,”
`Journal of Cellular and Comparative Physiology 54(S1):245-258
`(1959)
`IPR2018-00291, -00318, -00322, -00385, -00797, March 5, 2019
`Oral Hearing Transcript (Paper 62)
`
`Timsit, Y, “DNA structure and polymerase fidelity,” J Mol Biol,
`293(4):835-853 (1999)
`
`Goodman, M. F. & D. K. Fygenson, “DNA polymerase fidelity:
`From genetics toward a biochemical understanding,” Genetics,
`148(4):1475-1482 (1998)
`Goodman, M. F. & B. Tippin, “Sloppier copier DNA polymerases
`involved in genome repair,” Curr Opin Genet Dev, 10(2):162-168
`(2000)
`Kunkel, T. A., “The mutational specificity of DNA polymerase-
`beta during in vitro DNA synthesis. Production of frameshift, base
`substitution, and deletion mutations,” J Biol Chem, 260(9):5787-
`5796 (1985)
`Wong, I., S. S. Patel & K. A. Johnson, “An induced-fit kinetic
`mechanism for DNA replication fidelity: direct measurement by
`single-turnover kinetics,” Biochemistry, 30(2):526-537 (1991)
`Tan, X., C. K. Chu & F. D. Boudinot, “Development and
`optimization of anti-HIV nucleoside analogs and prodrugs: A
`review of their cellular pharmacology, structure-activity
`relationships and pharmacokinetics,” Adv Drug Deliv Rev, 39(1-
`3):117-151 (1999)
`Ito, J. & D. K. Braithwaite, “Compilation and alignment of DNA
`polymerase sequences,” Nucleic Acids Res, 19(15):4045-4057
`(1991)
`
`
`
`Dated: March 30, 2021
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/John P. White/
`
`
`
`
`
`
`By:
`
`5
`
`
`
`Case IPR2020-00988
`Patent No. 10,407,458
`
`
`
`
`
`
`
`
`John P. White, Reg. No. 28,678
`Lead Attorney for Patent Owner
`Cooper & Dunham LLP
`30 Rockefeller Plaza, 20th Floor
`New York, NY 10112
`Telephone: (212) 278-0400
`Fax: (212) 391-0525
`
`Gary J. Gershik, Reg. No. 39,992
`Cooper & Dunham LLP
`30 Rockefeller Plaza, 20th Floor
`New York, NY 10112
`Telephone: (212) 278-0400
`Fax: (212) 391-0525
`
`John D. Murnane, Reg. No. 29,836
`VENABLE LLP
`JDMurnane@Venable.com
`1290 Avenue of the Americas
`New York, NY 10104
`Telephone: (212) 218-2100
`Fax: (212) 218-2200
`
`Justin J. Oliver, Reg. No. 44,986
`VENABLE LLP
`JOliver@Venable.com
`600 Massachusetts Ave.
`Washington, D.C. 20001
`Tel: (202) 721-5423
`Fax: (212) 218-2200
`
`
`6
`
`
`
`Case IPR2020-00988
`Patent No. 10,407,458
`
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that a true and correct copy of the foregoing PATENT
`
`OWNER’S UPDATED EXHIBIT LIST and EXHIBITS 2054, 2059, 2071-2089
`
`are being served on March 30, 2021, via email to Counsel for Petitioner at the email
`
`addresses below:
`
`
`
`Kerry S. Taylor
`Nathanael R. Luman
`Michael L. Fuller
`KNOBBE, MARTENS, OLSON
`& BEAR, LLP
`2040 Main Street, 14th Floor
`Irvine, CA 92614
`Email: BoxIllumina@knobbe.com
`
`
`Dated: March 30, 2021
`
`
`
`
`
`By:
`
`
`
`/John P. White/
`John P. White, Reg. No. 28,678
`Lead Attorney for Patent Owner
`Cooper & Dunham LLP
`30 Rockefeller Plaza, 20th Floor
`New York, NY 10112
`Telephone: (212) 278-0400
`Fax: (212) 391-0525
`
`
`
`
`
`